335 related articles for article (PubMed ID: 37417238)
21. [Management strategies for chronic liver disease-related thrombocytopenia].
Qian JD; Yao TT; Wang Y; Wang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):896-899. PubMed ID: 34638215
[TBL] [Abstract][Full Text] [Related]
22. Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
Orme ME; Bentley R; Marcella S; Peck-Radosavljevic M; Perard R; Wedemeyer H; Yoshiji H; Agarwal K; Dusheiko G
Adv Ther; 2022 Sep; 39(9):4169-4188. PubMed ID: 35836089
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
Ding JN; Feng TT; Sun W; Cai XY; Zhang Y; Zhao WF
World J Gastrointest Surg; 2022 Nov; 14(11):1260-1271. PubMed ID: 36504518
[TBL] [Abstract][Full Text] [Related]
24. Complications and outcomes in chronic liver disease.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2011 May; 27(3):204-9. PubMed ID: 21451410
[TBL] [Abstract][Full Text] [Related]
25. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
[TBL] [Abstract][Full Text] [Related]
26. Coagulopathy in Children With Liver Disease.
Kawada PS; Bruce A; Massicotte P; Bauman M; Yap J
J Pediatr Gastroenterol Nutr; 2017 Dec; 65(6):603-607. PubMed ID: 28837506
[TBL] [Abstract][Full Text] [Related]
27. Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography.
Lloyd-Donald P; Vasudevan A; Angus P; Gow P; Mårtensson J; Glassford N; Eastwood GM; Hart GK; Bellomo R
J Crit Care; 2017 Apr; 38():215-224. PubMed ID: 27978499
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis.
Loffredo L; Violi F
Dig Liver Dis; 2019 Jan; 51(1):24-27. PubMed ID: 29958825
[TBL] [Abstract][Full Text] [Related]
29. Association of Chronic Liver Disease and Mortality in Patients With Aneurysmal Subarachnoid Hemorrhage.
Zhang Y; Li L; Jia L; Chong W; Hai Y; Lunsford LD; You C; Cheng Y; Fang F
Stroke; 2021 Oct; 52(10):e614-e617. PubMed ID: 34281381
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of Bariatric Surgery in Chronic Liver Disease: a National Inpatient Sample Analysis.
Mavilia MG; Wakefield D; Karagozian R
Obes Surg; 2020 Mar; 30(3):941-947. PubMed ID: 31863408
[TBL] [Abstract][Full Text] [Related]
31. Hematologic manifestations of liver disease.
Marks PW
Semin Hematol; 2013 Jul; 50(3):216-21. PubMed ID: 23953338
[TBL] [Abstract][Full Text] [Related]
32. Review article: thrombocytopenia in chronic liver disease.
Poordad F
Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():5-11. PubMed ID: 17958514
[TBL] [Abstract][Full Text] [Related]
33. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.
Than NN; Tomlinson CL; Haldar D; King AL; Moore D; Newsome PN
Syst Rev; 2016 Jun; 5():100. PubMed ID: 27301957
[TBL] [Abstract][Full Text] [Related]
34. Coagulation abnormalities in patients who have liver disease.
Trotter JF
Clin Liver Dis; 2006 Aug; 10(3):665-78, x-xi. PubMed ID: 17162234
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 and hepatorenal syndrome.
Wu HHL; Athwal VS; Kalra PA; Chinnadurai R
World J Gastroenterol; 2022 Oct; 28(39):5666-5678. PubMed ID: 36338894
[TBL] [Abstract][Full Text] [Related]
36. Managing diabetes in patients with chronic liver disease.
Khan R; Foster GR; Chowdhury TA
Postgrad Med; 2012 Jul; 124(4):130-7. PubMed ID: 22913901
[TBL] [Abstract][Full Text] [Related]
37. [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features].
Kalmykova ZA; Kononenko IV; Mayorov AY
Ter Arkh; 2019 Dec; 91(12):115-121. PubMed ID: 32598598
[TBL] [Abstract][Full Text] [Related]
38. Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis.
Li J; Han B; Li H; Deng H; Méndez-Sánchez N; Guo X; Qi X
Saudi J Gastroenterol; 2018; 24(4):220-227. PubMed ID: 29956689
[TBL] [Abstract][Full Text] [Related]
39. Is coagulopathic liver disease a factor in spontaneous cerebral hemorrhage?
Lee HJ; Hinrichs CR
J Comput Assist Tomogr; 2002; 26(1):69-72. PubMed ID: 11801906
[TBL] [Abstract][Full Text] [Related]
40. Restless legs syndrome among subjects having chronic liver disease: A systematic review and meta-analysis.
Gupta R; Gupta R; Kumar N; Rawat VS; Ulfberg J; Allen RP
Sleep Med Rev; 2021 Aug; 58():101463. PubMed ID: 33836477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
